Company Search:
Advanced Search
Sponsored Links
Elanix Biotechnologies AG Company Snapshot
Elanix Biotechnologies AG operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Elanix Biotechnologies AG with three other drug stores in Europe: Delko SA of Poland (2006 sales of 255.95 million Polish New Zlotys [US$65.16 million] ), Navamedic ASA of Norway (386,451.00 Norwegian Kroner [US$47,506.42 ] of which 100% was Vitaflo Scandinavia A), and Medios AG (1.67 million Euro [US$1.83 million] of which 100% was Animation films).

Sales Analysis.
  Stock Performance Chart for Elanix Biotechnologies AG
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 2.25
(Figures in Euro)
1 Week 4.7%   13 Weeks 16.9%  
4 Weeks 36.4%   52 Weeks 41.8%  
Elanix Biotechnologies AG Key Data:
  Ticker: ELN Country: Germany
  Exchanges: DUS FRA OTH Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2006 Sales 67,415
(Year Ending Jan 2007).
  Currency: Euro Market Cap: 1,162,350
  Fiscal Yr Ends: December Shares Outstanding: 516,600
  Share Type: Stammaktie Closely Held Shares: 220,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.